Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Am J Respir Crit Care Med
    July 2021
  1. KATAYAMA S, Tonai K, Minakata D, Nunomiya S, et al
    Pseudomembranous Invasive Tracheobronchial Aspergillosis.
    Am J Respir Crit Care Med. 2021 Jul 8. doi: 10.1164/rccm.202009-3659.
    >> Share

    June 2021
  2. ROELENS M, Battista Migliori G, Rozanova L, Estill J, et al
    Evidence-based Definition for Extensively Drug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2021 Jun 9. doi: 10.1164/rccm.202009-3527.
    >> Share

    May 2021
  3. WELLS G, Glasgow JN, Nargan K, Lumamba K, et al
    microCT Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in 3D Granuloma Morphology.
    Am J Respir Crit Care Med. 2021 May 20. doi: 10.1164/rccm.202101-0032.
    >> Share

  4. LONG DR, Wolter DJ, Lee M, Precit M, et al
    Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus aureus Airway Infection.
    Am J Respir Crit Care Med. 2021;203:1127-1137.
    >> Share

    April 2021

  5. Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2021;203:1045.
    >> Share

  6. HUGHES DA, Price H, Rosenthal M, Davies JC, et al
    Pseudomonas aeruginosa in the Cystic Fibrosis Airway: Does It Deserve Its Reputation as a Predatory "Bully"?
    Am J Respir Crit Care Med. 2021;203:1027-1030.
    >> Share

  7. HUDDART S, Savic RM, Cattamanchi A
    Is Glycemic Control the Secret to Tuberculosis Control?
    Am J Respir Crit Care Med. 2021 Apr 7. doi: 10.1164/rccm.202103-0703.
    >> Share

  8. MILLER JO, Shih AR, Mino-Kenudson M, Taylor MS, et al
    Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.
    Am J Respir Crit Care Med. 2021;203:918-921.
    >> Share

    March 2021
  9. BEHR MA, Kaufmann E, Duffin J, Edelstein PH, et al
    Latent Tuberculosis: Two Centuries of Confusion.
    Am J Respir Crit Care Med. 2021 Mar 24. doi: 10.1164/rccm.202011-4239.
    >> Share

  10. LIU Q, You N, Pan H, Shen Y, et al
    Glycemic Trajectories After Tuberculosis Diagnosis and Treatment Outcomes of New Tuberculosis Patients: A Prospective Study in Eastern China.
    Am J Respir Crit Care Med. 2021 Mar 11. doi: 10.1164/rccm.202007-2634.
    >> Share

  11. KENDALL EA, Shrestha S, Dowdy DW
    Reply to: Subclinical Tuberculosis: Some Flies in the Ointment.
    Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202102-0367.
    >> Share

  12. PIERCE CW
    Subclinical Tuberculosis: Some Flies in the Ointment.
    Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202101-0227.
    >> Share

  13. LE ROUX SP, Upton C, Vanker N, Dooley KE, et al
    Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.
    Am J Respir Crit Care Med. 2021;203:635-637.
    >> Share

  14. IOVINO F, Henriques-Normark B
    Experimental Model for Studies of Pneumococcal Colonization in Older Adults.
    Am J Respir Crit Care Med. 2021;203:539-540.
    >> Share

  15. JORTH P, Durfey S, Rezayat A, Garudathri J, et al
    Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting Pseudomonas aeruginosa.
    Am J Respir Crit Care Med. 2021;203:637-640.
    >> Share

  16. BUETTI N, Mimoz O, Schwebel C, Ruckly S, et al
    Insertion Site and Infection Risk among Peripheral Arterial Catheters.
    Am J Respir Crit Care Med. 2021;203:630-633.
    >> Share

  17. ADLER H, German EL, Mitsi E, Nikolaou E, et al
    Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.
    Am J Respir Crit Care Med. 2021;203:604-613.
    >> Share

    February 2021
  18. ESCALANTE P, Wilson JW
    New Diagnostics to Infer Risk in Tuberculosis: Is the Term Latent Tuberculosis Infection Obsolete?
    Am J Respir Crit Care Med. 2021 Feb 17. doi: 10.1164/rccm.202101-0131.
    >> Share

    January 2021
  19. LOUGHLIN L, McAuley DF, Simpson AJ, McMullan R, et al
    Reply to: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
    Am J Respir Crit Care Med. 2021 Jan 26. doi: 10.1164/rccm.202101-0026.
    >> Share

  20. ABEREGG SK, Wolfe BM
    Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
    Am J Respir Crit Care Med. 2021 Jan 26. doi: 10.1164/rccm.202012-4486.
    >> Share

  21. HAMAD AM, Rea F, Haroon S
    Bronchial Atresia and Bronchogenic Cyst with Saprophytic Aspergilloma.
    Am J Respir Crit Care Med. 2021 Jan 25. doi: 10.1164/rccm.202010-3876.
    >> Share

  22. AKSAMIT TR
    One Step Closer: Nontuberculous Mycobacterial Pulmonary Disease and Predicted Mortality-The BACES Score.
    Am J Respir Crit Care Med. 2021;203:163-164.
    >> Share

  23. KIM HJ, Kwak N, Hong H, Kang N, et al
    BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease.
    Am J Respir Crit Care Med. 2021;203:230-236.
    >> Share

  24. HARRISON F, Smyth AR
    Professor Pangloss and the Pangenome: Does Staphylococcus aureus Have the Best of All Possible Worlds?
    Am J Respir Crit Care Med. 2021 Jan 11. doi: 10.1164/rccm.202012-4533.
    >> Share

  25. MPANDE CAM, Musvosvi M, Rozot V, Mosito B, et al
    Antigen-specific T Cell Activation Distinguishes Between Recent and Remote Tuberculosis Infection.
    Am J Respir Crit Care Med. 2021 Jan 6. doi: 10.1164/rccm.202007-2686.
    >> Share

  26. FRANKE MF, Khan P, Hewison C, Khan U, et al
    Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
    Am J Respir Crit Care Med. 2021;203:111-119.
    >> Share

    December 2020
  27. WAUTERS J, Lamoth F, Rijnders BJ, Calandra T, et al
    Invasive Pulmonary Aspergillosis Goes Viral Again?
    Am J Respir Crit Care Med. 2020 Dec 22. doi: 10.1164/rccm.202012-4413.
    >> Share

  28. RAMOS-SEVILLANO E, Ercoli G, Felgner P, Ramiro de Assis R, et al
    Preclinical Development of Virulence Attenuated Streptococcus pneumoniae Strains Able to Enhance Protective Immunity Against Pneumococcal Infection.
    Am J Respir Crit Care Med. 2020 Dec 17. doi: 10.1164/rccm.202011-4161.
    >> Share

  29. FEKKAR A, Lampros A, Mayaux J, Poignon C, et al
    Occurrence of Invasive Pulmonary Fungal Infections in Severe COVID-19 Patients Admitted to the ICU.
    Am J Respir Crit Care Med. 2020 Dec 2. doi: 10.1164/rccm.202009-3400.
    >> Share

  30. HOSODA C, Ishiguro T, Shimizu Y, Kanegane H, et al
    Mycobacterium genavense Infection Presenting as an Endobronchial Polyp and Upper Lobe Atelectasis.
    Am J Respir Crit Care Med. 2020;202:e144-e145.
    >> Share

    November 2020
  31. KENDALL EA, Shrestha S, Dowdy DW
    The Epidemiological Importance of Subclinical Tuberculosis: A Critical Re-Appraisal.
    Am J Respir Crit Care Med. 2020 Nov 16. doi: 10.1164/rccm.202006-2394.
    >> Share

  32. WU BG, Sulaiman I, Tsay JJ, Perez L, et al
    Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary Th17 Response that Mitigates Susceptibility to Streptococcus pneumoniae.
    Am J Respir Crit Care Med. 2020 Nov 9. doi: 10.1164/rccm.202005-1596.
    >> Share

    October 2020
  33. SI X, Shi J
    Pulmonary and Skeletal Infection of Mycobacterium kansasii.
    Am J Respir Crit Care Med. 2020;202:1169-1170.
    >> Share

  34. GARDNER AI, Haq IJ, Simpson AJ, Becker KA, et al
    Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1133-1145.
    >> Share

  35. OCAK S, d'Odemont JP
    Cavernoscopic Views of a Pleural Aspergillosis.
    Am J Respir Crit Care Med. 2020 Oct 6. doi: 10.1164/rccm.202004-0927.
    >> Share

  36. HONDA JR
    Reply to Ward et al.: Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1062.
    >> Share

  37. WARD C, Al Momani H, Perry A, Perry JD, et al
    Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1061.
    >> Share

  38. SHALLER BD, Chen SB, Ho DY, Yu DH, et al
    Atypical Blastomycosis Masquerading as Lofgren Syndrome.
    Am J Respir Crit Care Med. 2020;202:1035-1036.
    >> Share

    September 2020
  39. BLAIZE M, Mayaux J, Luyt CE, Lampros A, et al
    COVID-19 Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Am J Respir Crit Care Med. 2020 Sep 17. doi: 10.1164/rccm.202007-2938.
    >> Share

  40. MENON AA, Berg DD, Gay EB, Fredenburgh LE, et al
    Reply to: COVID-19 Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Am J Respir Crit Care Med. 2020 Sep 17. doi: 10.1164/rccm.202008-3174.
    >> Share


  41. Erratum: Lower Bacillus Calmette-Guerin Protection against Mycobacterium tuberculosis Infection after Exposure to Beijing Strains.
    Am J Respir Crit Care Med. 2020;202:909-910.
    >> Share

  42. CHANG KC, Yew WW
    ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?
    Am J Respir Crit Care Med. 2020;202:777-778.
    >> Share

  43. SOTGIU G, Battista Migliori G, Menzies D, Mase S, et al
    Reply to Chang and Yew.
    Am J Respir Crit Care Med. 2020;202:778-779.
    >> Share

    August 2020
  44. WOLTER DJ, Ramsey BW
    Not Quite the Bully in the Schoolyard: Staphylococcus aureus Can Survive and Co-exist with Pseudomonas aeruginosa in the Cystic Fibrosis Lung.
    Am J Respir Crit Care Med. 2020 Aug 26. doi: 10.1164/rccm.202008-3077.
    >> Share

  45. BURZYNSKI J, Keshavjee S
    Supporting a Comprehensive, International Approach to Global Tuberculosis Eradication is the Right Thing to Do.
    Am J Respir Crit Care Med. 2020 Aug 24. doi: 10.1164/rccm.202007-2976.
    >> Share

  46. O'DONNELL M, Mathema B
    Operational Research on the Treatment of Drug-resistant Tuberculosis: Exciting Results that Need to be Protected.
    Am J Respir Crit Care Med. 2020 Aug 21. doi: 10.1164/rccm.202007-2974.
    >> Share

  47. KYRIAZOPOULOU E, Liaskou-Antoniou L, Adamis G, Panagaki A, et al
    Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis: A Randomized Trial.
    Am J Respir Crit Care Med. 2020 Aug 6. doi: 10.1164/rccm.202004-1201.
    >> Share

  48. FISCHER AJ, Singh SB, LaMarche MM, Maakestad LJ, et al
    Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020 Aug 4. doi: 10.1164/rccm.202004-1322.
    >> Share

  49. DAWRS SN, Kautz M, Chan ED, Honda JR, et al
    Mycobacterium abscessus and Gastroesophageal Reflux: An In Vitro Study.
    Am J Respir Crit Care Med. 2020;202:466-469.
    >> Share

  50. KOHLMAIER B, Strenger V, Egger M, Modl M, et al
    Persistent Stridor in a 10-Year-Old Patient with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:e72-e73.
    >> Share

    July 2020
  51. TORRES A, Martin Loeches I
    Invasive Pulmonary Aspergillosis in Ventilator-Associated Pneumonia: The Hidden Enemy?
    Am J Respir Crit Care Med. 2020 Jul 30. doi: 10.1164/rccm.202006-2605.
    >> Share

  52. SCHLUGER NW
    Prevention of Multidrug-resistant Tuberculosis in Close Contacts: Back to the Future?
    Am J Respir Crit Care Med. 2020 Jul 27. doi: 10.1164/rccm.202006-2488.
    >> Share

  53. VAN ARKEL ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, et al
    Reply to: Fungal Infection During COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
    Am J Respir Crit Care Med. 2020 Jul 20. doi: 10.1164/rccm.202006-2241.
    >> Share

  54. FEKKAR A, Poignon C, Blaize M, Lampros A, et al
    Fungal Infection During COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
    Am J Respir Crit Care Med. 2020 Jul 20. doi: 10.1164/rccm.202005-1945.
    >> Share

  55. VAN BIESEN S, Kwa D, Bosman RJ, Juffermans NP, et al
    Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Non-directed Bronchoalveolar Lavage.
    Am J Respir Crit Care Med. 2020 Jul 15. doi: 10.1164/rccm.202005-2018.
    >> Share

  56. MENZIES NA, Bellerose M, Testa C, Swartwood N, et al
    Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States.
    Am J Respir Crit Care Med. 2020 Jul 9. doi: 10.1164/rccm.202003-0526.
    >> Share

  57. PODANY AT
    Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention.
    Am J Respir Crit Care Med. 2020 Jul 7. doi: 10.1164/rccm.202006-2144.
    >> Share

  58. CUTLER T, Scales D, Levine W, Schluger N, et al
    A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jul 1. doi: 10.1164/rccm.202003-0828.
    >> Share

  59. LOUGHLIN L, Hellyer TP, White PL, McAuley DF, et al
    Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK Intensive Care Units.
    Am J Respir Crit Care Med. 2020 Jul 1. doi: 10.1164/rccm.202002-0355.
    >> Share

    June 2020
  60. RODRIGUEZ CA, Sy KTL, Mitnick CD, Franke MF, et al
    Time Dependent Confounding in Tuberculosis Treatment Outcome Analyses: A Review of a Source of Bias.
    Am J Respir Crit Care Med. 2020 Jun 18. doi: 10.1164/rccm.202001-0220.
    >> Share

  61. HUANG CC, Becerra MC, Calderon R, Contreras C, et al
    Isoniazid Preventive Therapy in Contacts of Multidrug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jun 17. doi: 10.1164/rccm.201908-1576.
    >> Share

  62. VAN DE VEERDONK FL, Wauters J, Verweij PE
    Invasive Aspergillus Tracheobronchitis Emerging as Highly Lethal Complication of Severe Influenza.
    Am J Respir Crit Care Med. 2020 Jun 10. doi: 10.1164/rccm.202005-1883.
    >> Share


  63. Erratum: Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2020;201:1454.
    >> Share

  64. JAIN S, Kumar P, Goyal JP
    Utility of Xpert Ultra on Different Respiratory Specimens in Children.
    Am J Respir Crit Care Med. 2020;201:1452.
    >> Share

  65. ZAR HJ
    Reply to Jain et al.: Utility of Xpert Ultra on Different Respiratory Specimens in Children.
    Am J Respir Crit Care Med. 2020;201:1452-1453.
    >> Share

    May 2020
  66. HIBINO M, Horiuchi S, Kondo T
    Localized Tracheal Cryptococcosis Misdiagnosed as Severe Refractory Asthma.
    Am J Respir Crit Care Med. 2020 May 27. doi: 10.1164/rccm.202001-0032.
    >> Share

  67. SCHEUERMANN L, Pei G, Domaszewska T, Zyla J, et al
    Platelets Restrict the Oxidative Burst in Phagocytes and Facilitate Primary Progressive Tuberculosis.
    Am J Respir Crit Care Med. 2020 May 18. doi: 10.1164/rccm.201910-2063.
    >> Share

  68. HIBMA JE, Radtke KK, Dorman SE, Jindani A, et al
    Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection.
    Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.201912-2489.
    >> Share

  69. MENON AA, Berg DD, Brea EJ, Deutsch AJ, et al
    A Case of COVID-19 and Pneumocystis jirovecii Co-infection.
    Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.202003-0766.
    >> Share

  70. DAVIDS M, Pooran A, Hermann C, Mottay L, et al
    A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guerin.
    Am J Respir Crit Care Med. 2020;201:1277-1291.
    >> Share

  71. NYGA R, Maizel J, Nseir S, Chouaki T, et al
    Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza.
    Am J Respir Crit Care Med. 2020 May 14. doi: 10.1164/rccm.201910-1931.
    >> Share

  72. VAN ARKEL ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, et al
    COVID-19 Associated Pulmonary Aspergillosis.
    Am J Respir Crit Care Med. 2020 May 12. doi: 10.1164/rccm.202004-1038.
    >> Share

  73. KLOUDA T, Chiel L, Davis J, Boyer D, et al
    Pediatric Lung Transplant: Influences of Viral and Fungal Infections on Outcomes and Viral Markers as a Predictor of Outcome.
    Am J Respir Crit Care Med. 2020;201:1146-1148.
    >> Share

  74. SHAH P, Woytanowski JR, Hadeh A, Sockrider M, et al
    Pneumococcal (Pneumonia) Vaccines.
    Am J Respir Crit Care Med. 2020;201:P17-P18.
    >> Share

    April 2020
  75. DHEDA K, Davids M
    Latent Tuberculosis Infection-associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?
    Am J Respir Crit Care Med. 2020;201:895-898.
    >> Share

  76. STOUT JE, Turner NA, Belknap RW, Horsburgh CR, et al
    Reply to: Trials of Tuberculosis Preventive Therapy in People with HIV Infection.
    Am J Respir Crit Care Med. 2020 Apr 13. doi: 10.1164/rccm.202003-0855.
    >> Share

  77. SWINDELLS S, Hughes M, Chaisson RE
    Trials of Tuberculosis Preventive Therapy in People with HIV Infection.
    Am J Respir Crit Care Med. 2020 Apr 13. doi: 10.1164/rccm.202003-0761.
    >> Share

    March 2020
  78. DOOLEY KE, Miyahara S, von Groote-Bidlingmaier F, Sun X, et al
    Reply to: High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2020 Mar 4. doi: 10.1164/rccm.202002-0359.
    >> Share

  79. DECROO T, de Jong BC, Piubello A, Souleymane MB, et al
    High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2020 Mar 4. doi: 10.1164/rccm.202001-0201.
    >> Share

    February 2020
  80. GAO YH, Abo Leyah H, Finch S, Lonergan M, et al
    The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis.
    Am J Respir Crit Care Med. 2020 Feb 25. doi: 10.1164/rccm.201910-1972.
    >> Share

  81. KENG LT, Lee CF
    Ultrasound-Guided Transthoracic Needle Aspiration to Diagnose Invasive Pulmonary Aspergillosis.
    Am J Respir Crit Care Med. 2020 Feb 20. doi: 10.1164/rccm.202001-0008.
    >> Share

  82. WASSERMAN S, Furin J
    Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations.
    Am J Respir Crit Care Med. 2020 Feb 20. doi: 10.1164/rccm.202002-0264.
    >> Share


  83. Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2020;201:500-501.
    >> Share

  84. VERNON A, Bishai W
    Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
    Am J Respir Crit Care Med. 2020;201:405-406.
    >> Share

  85. ANDRES S, Merker M, Heyckendorf J, Kalsdorf B, et al
    Bedaquiline-resistant Tuberculosis: Dark Clouds on the Horizon.
    Am J Respir Crit Care Med. 2020 Feb 13. doi: 10.1164/rccm.201909-1819.
    >> Share

    January 2020
  86. DE JAGER VR, Vanker N, van der Merwe L, van Brakel E, et al
    Optimising beta-lactams Against Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jan 10. doi: 10.1164/rccm.201911-2149.
    >> Share

  87. VERRALL AJ, Chaidir L, Ruesen C, Apriani L, et al
    Lower BCG Protection Against Mycobacterium tuberculosis Infection After Exposure to Beijing Strains.
    Am J Respir Crit Care Med. 2020 Jan 8. doi: 10.1164/rccm.201912-2349.
    >> Share

  88. NICHOLS DP, Moss RB
    Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2309.
    >> Share

  89. MCSHANE H
    Controlled Human Infection Models - Is it Really Feasible to Give People Tuberculosis?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2408.
    >> Share

    December 2019
  90. GUPTA RK, Lipman M, Jackson C, Sitch A, et al
    Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study.
    Am J Respir Crit Care Med. 2019 Dec 11. doi: 10.1164/rccm.201905-0969.
    >> Share

  91. ABUBAKAR I, Cobelens FG, Rangaka MX
    The Risk of Falsely Declaring Non-Inferiority of Novel Latent Tuberculosis Treatment in Large Trials.
    Am J Respir Crit Care Med. 2019 Dec 9. doi: 10.1164/rccm.201911-2258.
    >> Share

    November 2019
  92. NISHIZAWA S, Tobino K
    Asymptomatic Tuberculous Pleurisy Mimicking Mesothelioma.
    Am J Respir Crit Care Med. 2019 Nov 25. doi: 10.1164/rccm.201906-1223.
    >> Share

  93. BREUER O, Schultz A, Garratt LW, Turkovic L, et al
    Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019 Nov 20. doi: 10.1164/rccm.201908-1585.
    >> Share

  94. NAHID P, Mase SR, Migliori GB, Sotgiu G, et al
    Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2019;200:e93-e142.
    >> Share

  95. STOUT JE, Turner NA, Belknap RW, Horsburgh CR, et al
    Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201908-1606.
    >> Share

  96. NARITA M, Sullivan Meissner J, Burzynski J
    Use of Modeling to Inform Tuberculosis Elimination Strategies.
    Am J Respir Crit Care Med. 2019 Nov 7. doi: 10.1164/rccm.201910-2061.
    >> Share

    October 2019
  97. BROWN JS
    Improving Pulmonary Immunity to Bacterial Pathogens Through Streptococcus pneumoniae Colonisation of the Nasopharynx.
    Am J Respir Crit Care Med. 2019 Oct 30. doi: 10.1164/rccm.201910-2047.
    >> Share

  98. TEZERA LB, Mansour S, Elkington P
    Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.
    Am J Respir Crit Care Med. 2019 Oct 28. doi: 10.1164/rccm.201908-1506.
    >> Share

  99. FOREMAN TW, Bucsan AN, Mehra S, Peloquin C, et al
    Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2019 Oct 24. doi: 10.1164/rccm.201903-0646.
    >> Share

  100. MENZIES NA, Parriott A, Shrestha S, Dowdy DW, et al
    Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California.
    Am J Respir Crit Care Med. 2019 Oct 18. doi: 10.1164/rccm.201907-1289.
    >> Share

    September 2019
  101. SURETTE MG, Bowdish DME
    Loss of Microbial Topography Precedes Infection in Infants.
    Am J Respir Crit Care Med. 2019;200:660-662.
    >> Share

  102. SAGAR AS, Dodge DL, Salahuddin M, Warner MT, et al
    Pleural Diseases: Pleurodesis via Indwelling Pleural Catheter, Dasatinib-induced Pleural Effusion, and IL-27 in Tuberculosis Pleural Effusion.
    Am J Respir Crit Care Med. 2019;200:771-773.
    >> Share

  103. KOTTHOFF-BURRELL E
    Candidemia (Blood Infection) and Other Candida Infections.
    Am J Respir Crit Care Med. 2019;200:P9-P10.
    >> Share

    August 2019
  104. ORTON CM, Garner JL, Desai SR, Kemp SV, et al
    Aspergillus Cavitation Complicating Endobronchial Lung Volume Reduction Coil Placement.
    Am J Respir Crit Care Med. 2019 Aug 30. doi: 10.1164/rccm.201906-1176.
    >> Share

  105. SCHAAF HS, Marais BJ
    The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children.
    Am J Respir Crit Care Med. 2019 Aug 6. doi: 10.1164/rccm.201907-1492.
    >> Share

  106. ZAR HJ, Workman LJ, Prins M, Bateman LJ, et al
    Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2019 Aug 5. doi: 10.1164/rccm.201904-0772.
    >> Share

  107. PARIKH R, Belok SH, Swamy L, Reardon CC, et al
    Adjunctive Therapies in the Management of Septic Shock.
    Am J Respir Crit Care Med. 2019;200:381-383.
    >> Share

    July 2019
  108. PRAZAK J, Iten M, Cameron DR, Save J, et al
    Bacteriophages Improve Outcome in Experimental Staphylococcus Aureus Ventilator Associated Pneumonia.
    Am J Respir Crit Care Med. 2019 Jul 1. doi: 10.1164/rccm.201812-2372.
    >> Share

    June 2019
  109. MEEGAN JE, Bastarache JA
    NET Gain for Sepsis Research: New Approach to Assess Neutrophil Function in Patients.
    Am J Respir Crit Care Med. 2019 Jun 11. doi: 10.1164/rccm.201905-1074.
    >> Share

    May 2019
  110. SEMLER MW, Singer M
    Deconstructing Hyperlactatemia in Sepsis Using ScvO2 and Base Deficit.
    Am J Respir Crit Care Med. 2019 May 19. doi: 10.1164/rccm.201904-0899.
    >> Share

  111. GAUTAM S, Sharma L, Dela Cruz CS
    Teaching an Old Intensivist Neutrophil Tricks: Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia.
    Am J Respir Crit Care Med. 2019;199:1178-1181.
    >> Share

  112. SANDERS DB, Nichols DP
    Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019;199:1181-1182.
    >> Share

  113. NIEDERMAN MS, Nair GB, Matt U, Herold S, et al
    Update in Lung Infections and Tuberculosis 2018.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0606.
    >> Share

  114. VAN DE GROEP K, Verboom DM, van de Veerdonk FL, Haas PA, et al
    Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: the Role of Plasma Galactomannan.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0587.
    >> Share

  115. RUSSELL JA, Gordon AC, Walley KR
    Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock.
    Am J Respir Crit Care Med. 2019;199:1049-1051.
    >> Share

    April 2019
  116. KRANZER K, Kalsdorf B, Heyckendorf J, Andres S, et al
    New WHO Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
    Am J Respir Crit Care Med. 2019 Apr 26. doi: 10.1164/rccm.201902-0260.
    >> Share

  117. GUPTA E, Jacobs MD, George G, Roman J, et al
    Beyond the ICU: Frailty and Post-ICU Disability. Healthcare Use after Acute Respiratory Distress Syndrome and Severe Sepsis.
    Am J Respir Crit Care Med. 2019;199:1028-1030.
    >> Share

    March 2019
  118. PRESCOTT HC
    Identifying Sepsis Subtypes from Routine Clinical Data.
    Am J Respir Crit Care Med. 2019 Mar 8. doi: 10.1164/rccm.201903-0532.
    >> Share

    January 2019
  119. DHEDA K, Lenders L, Srivastava S, Magombedze G, et al
    Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
    Am J Respir Crit Care Med. 2019 Jan 29. doi: 10.1164/rccm.201807-1361.
    >> Share

  120. TE BRAKE LHM, Boeree MJ, Aarnoutse RE
    Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201811-2101.
    >> Share

  121. VELASQUEZ GE, Brooks MB, Coit JM, Sanchez Garavito E, et al
    Reply to: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201812-2281.
    >> Share

  122. HANSEN C, Scupp T, Nelson J, Brainard J, et al
    Implications of Procalcitonin Testing in Critically Ill Patients with Sepsis.
    Am J Respir Crit Care Med. 2019;199:232-234.
    >> Share

    December 2018
  123. SCICLUNA BP, Baillie JK
    The Search for Efficacious New Therapies in Sepsis Needs to Embrace Heterogeneity.
    Am J Respir Crit Care Med. 2018 Dec 12. doi: 10.1164/rccm.201811-2148.
    >> Share

    November 2018
  124. CONSONNI F, Nacoti M, Amini M, Vedovati S, et al
    Severe Necrotizing Staphylococcal Pneumonia with Late Life-Threatening Tracheo-Bronchial Involvement in Infant.
    Am J Respir Crit Care Med. 2018 Nov 15. doi: 10.1164/rccm.201803-0507.
    >> Share

  125. JONES TK, Wong HR, Meyer NJ
    HDL Cholesterol: A "Pathogen Lipid Sink" for Sepsis?
    Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201811-2084.
    >> Share

    October 2018
  126. SCHLUGER NW
    Tuberculosis Elimination, Research, and Respect for Persons.
    Am J Respir Crit Care Med. 2018 Oct 19. doi: 10.1164/rccm.201809-1623.
    >> Share

  127. KESHAVJEE S, Amanullah F, Cattamanchi A, Chaisson R, et al
    Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
    Am J Respir Crit Care Med. 2018 Oct 18. doi: 10.1164/rccm.201806-1053.
    >> Share

  128. MARTINEZ L, Andrews JR
    Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms.
    Am J Respir Crit Care Med. 2018 Oct 1. doi: 10.1164/rccm.201809-1702.
    >> Share

    September 2018
  129. YOON C, Semitala FC, Asege L, Katende J, et al
    Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201803-0490.
    >> Share

    August 2018
  130. ELKINGTON PT, Bateman AC, Thomas GJ, Ottensmeier CH, et al
    Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.
    Am J Respir Crit Care Med. 2018 Aug 24. doi: 10.1164/rccm.201807-1250.
    >> Share

    June 2018
  131. VELASQUEZ GE, Brooks MB, Coit JM, Pertinez H, et al
    Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2018 Jun 29. doi: 10.1164/rccm.201712-2524.
    >> Share

  132. DHEDA K, Lenders L, Magombedze G, Srivastava S, et al
    Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients.
    Am J Respir Crit Care Med. 2018 Jun 7. doi: 10.1164/rccm.201711-2333.
    >> Share

    May 2018
  133. LAN F, Zhang N, Holtappels G, Ruyck N, et al
    Staphylococcus aureus Induces Mucosal Type 2 Immune Response via Epithelial Cell Derived Cytokines.
    Am J Respir Crit Care Med. 2018 May 16. doi: 10.1164/rccm.201710-2112.
    >> Share

    April 2018
  134. MONEDERO-RECUERO I
    Drug-resistant Tuberculosis in Europe. What are We Waiting for?
    Am J Respir Crit Care Med. 2018 Apr 18. doi: 10.1164/rccm.201803-0497.
    >> Share

  135. SULIMAN S, Thompson E, Sutherland J, Weiner Rd J, et al
    Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.
    Am J Respir Crit Care Med. 2018 Apr 6. doi: 10.1164/rccm.201711-2340.
    >> Share

    March 2018
  136. ABUBAKAR I, Gupta RK, Rangaka MX, Lipman M, et al
    Update in Tuberculosis and Non-tuberculous Mycobacteria 2017.
    Am J Respir Crit Care Med. 2018 Mar 14. doi: 10.1164/rccm.201801-0106.
    >> Share

  137. COX D, Keane J
    Platelets and Tuberculosis: Small Cells, Not So Innocent Bystanders.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201802-0279.
    >> Share

  138. GUNTHER G, van Leth F, Alexandru S, Altet N, et al
    Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141.
    >> Share

    February 2018
  139. SCHWANDER S, Keane J
    Cause or Effect - the Elusive Role of Regulatory T Cells in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 28. doi: 10.1164/rccm.201802-0233.
    >> Share

  140. FOX KA, Kirwan DE, Whittington AM, Krishnan N, et al
    Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 8. doi: 10.1164/rccm.201710-2102.
    >> Share

    December 2017
  141. ERNST JD
    Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Dec 20. doi: 10.1164/rccm.201712-2368.
    >> Share


  142. What Is Sepsis?
    Am J Respir Crit Care Med. 2017;196:P21-P22.
    >> Share

    November 2017
  143. BENARD A, Sakwa I, Schierloh P, Colom A, et al
    B Cells Producing Type I Interferon Modulate Macrophage Polarization in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Nov 21. doi: 10.1164/rccm.201707-1475.
    >> Share

    October 2017
  144. DIVANGAHI M, Behr MA
    Cracking the Vaccine Code in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Oct 18. doi: 10.1164/rccm.201707-1489.
    >> Share

  145. MARTINEZ L, Handel A, Shen Y, Chakraburty S, et al
    A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts.
    Am J Respir Crit Care Med. 2017 Oct 16. doi: 10.1164/rccm.201706-1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016